Applications of neural network analyses to in vivo 1H magnetic resonance spectroscopy of epilepsy patients

Epilepsy Research

Volumn 35, Issue 3, 1999, Pages 245-252

  Bakken, Inger Johanne ^a   Axelson, David ^b   Kvistad, Kjell Arne ^c   Brodtkorb, Eylert ^c   Müller, Bernd ^c   Aasly, Jan ^c   Gribbestad, Ingrid Susann ^a  

^a SINTEF   (Norway)

^b QUEEN S UNIVERSITY   (Canada)

^c TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

Author keywords

Artificial neural network; Epilepsy; In vivo; Proton MR spectroscopy

Indexed keywords

N ACETYLASPARTIC ACID;

ADULT; ARTICLE; ARTIFICIAL NEURAL NETWORK; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EPILEPTIC FOCUS; FEMALE; HUMAN; MALE; NEUROSURGERY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; TEMPORAL LOBE EPILEPSY;

ADOLESCENT; ADULT; ASPARTIC ACID; BRAIN CHEMISTRY; CHOLINE; CREATINE; ELECTROENCEPHALOGRAPHY; EPILEPSY, TEMPORAL LOBE; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; NEURAL NETWORKS (COMPUTER);

EID: 0032997125     PISSN: 09201211     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-1211(99)00019-4     Document Type: Article

References (19)

1. Cendes F., Andermann F., Preul M.C., Arnold D.L. Lateralization of temporal-lobe epilepsy based on regional metabolic abnormalities in proton magnetic resonance spectroscopic images. Ann. Neurol. 35:1994;211-216.
2. Chu W.J., Hetherington H.P., Kuzniecky R.I., Simon T., Mason G.F., Elgavish G.A. Lateralization of human temporal lobe epilepsy by P-31 NMR spectroscopic imaging at 4.1 T. Neurology. 51:1998;472-479.
3. Connelly A., Jackson G.D., Duncan J.S., King M.D., Gadian D.G. Magnetic resonance spectroscopy in temporal lobe epilepsy. Neurology. 44:1994;1411-1417.
4. Connelly A., VanPaesschen W., Porter D.A., Johnson C.L., Duncan J.S., Gadian D.G. Proton magnetic resonance spectroscopy in MRI-negative temporal lobe epilepsy. Neurology. 51:1998;61-66.
5. Cross J.H., Connelly A., Jackson G.D., Johnson C.L., Neville B.G.R., Gadian D.G. Proton magnetic resonance spectroscopy in children with temporal lobe epilepsy. Ann. Neurol. 39:1996;107-113.
6. ElDeredy W. Pattern recognition approaches in biomedical and clinical magnetic resonance spectroscopy: A review. NMR Biomed. 10:1997;99-124.
7. Gilmore R., Morris H., Vanness P.C., Gilmore-pollak W., Estes M. Mirror focus - Function of seizure frequency and influence on outcome after surgery. Epilepsia. 35:1994;258-263.
8. Hagberg G. From magnetic resonance spectroscopy to classification of tumors. A review of pattern recognition methods. NMR Biomed. 11:1998;148-156.
9. Hugg J.W., Laxer K.D., Matson G.B., Maudsley A.A., Weiner M.W. Neuron loss localizes human temporal lobe epilepsy by in vivo proton magnetic resonance spectroscopic imaging. Ann. Neurol. 34:1993;788-794.
10. 1H NMR spectroscopy: N-acetyl aspartate, creatine and choline. NMR Biomed. 4:1991;47-52.
11. Preul M.C., Caramanos Z., Collins D.L., Villemure J.G., Leblanc R., Olivier A., Pokrupa R., Arnold D.L. Accurate, non-invasive diagnosis of human brain tumors by using proton magnetic resonance spectroscopy. Nature Med. 2:1996;323-325.
12. Ross B., Michaelis T. Clinical applications of magnetic resonance spectroscopy. Magn. Reson. Q. 10:1994;191-247.
13. Specht D.F. Probabilistic neural networks and the polynomial adaline as complementary techniques for classification. IEEE Trans. Neural Netw. 1:1990;111-121.
14. Specht D.F. A general regression neural network. IEEE Trans. Neural Netw. 2:1991;568-576.
15. Urenjak J., Williams S.R., Gadian D.G., Noble M. Specific expression of N-acetylaspartate in neurons, oligodendrocyte-type-2 astrocyte progenitors, and immature oligodendrocytes in vitro. J. Neurochem. 59:1992;55-61.
16. Urenjak J., Williams S.R., Gadian D.G., Noble M. Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types. J. Neurosci. 13:1993;981-989.
17. Usenius J.P., Tuohimetsa S., Vainio P., AlaKorpela M., Hiltunen Y., Kauppinen R.A. Automated classification of human brain tumours by neural network analysis using in vivo H-1 magnetic resonance spectroscopic metabolise phenotypes. NeuroReport. 7:1996;1597-1600.
18. 1H MRS in vivo. NeuroReport. 5:1994;1733-1736.
19. Wieser H.G. Epilepsy surgery: past, present and future. Seizure. 7:1998;173-184.